# Yusuke Suzuki

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yusuke-suzuki-2/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,541 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 57 |
| i10-index | 223 |
| Last Known Institution | Juntendo University |
| OpenAlex ID | https://openalex.org/A5076815130 |
| ORCID iD | 0000-0002-4077-9747 |
| Works | 513 |

## Researcher papers

- [KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases](https://scholariq.org/papers/kdigo-2021-clinical-practice-guideline-for-the-management-of-glomerular-diseases/)
- [Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group](https://scholariq.org/papers/oxford-classification-of-iga-nephropathy-2016-an-update-from-the-iga-nephropathy/)
- [Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy](https://scholariq.org/papers/global-kidney-health-2017-and-beyond-a-roadmap-for-closing-gaps-in-care-research/)
- [Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases](https://scholariq.org/papers/executive-summary-of-the-kdigo-2021-guideline-for-the-management-of-glomerular/)
- [Inflammation and angiotensin II](https://scholariq.org/papers/inflammation-and-angiotensin-ii/)
- [Evaluating a New International Risk-Prediction Tool in IgA Nephropathy](https://scholariq.org/papers/evaluating-a-new-international-risk-prediction-tool-in-iga-nephropathy/)
- [Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity](https://scholariq.org/papers/aberrantly-glycosylated-iga1-in-iga-nephropathy-patients-is-recognized-by-igg/)
- [Proinflammatory actions of angiotensins](https://scholariq.org/papers/proinflammatory-actions-of-angiotensins/)
- [Role of the Renin-Angiotensin System in Vascular Diseases](https://scholariq.org/papers/role-of-the-renin-angiotensin-system-in-vascular-diseases/)
- [IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis](https://scholariq.org/papers/iga-nephropathy-and-iga-vasculitis-with-nephritis-have-a-shared-feature/)
- [A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy](https://scholariq.org/papers/a-phase-2-trial-of-sibeprenlimab-in-patients-with-iga-nephropathy/)
- [A digest from evidence-based clinical practice guideline for IgA nephropathy 2020](https://scholariq.org/papers/a-digest-from-evidence-based-clinical-practice-guideline-for-iga-nephropathy/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Platelet Disorders and Treatments](https://scholariq.org/topics/platelet-disorders-and-treatments/)

## Researcher university

- [Juntendo University](https://scholariq.org/institutions/juntendo-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.